health
Dexcom RCT suggests CGM benefits for broad diabetes population
Why this matters: health reporting relevant to everyday decisions and well-being.
In this edition of STAT Health Tech: Dexcom's CGM trial, udpates from Apple's annual developers' conference, and wearables.
Read full story on STAT News → More top stories
Aggregated and edited by the Scoop newsroom. We surface news from STAT News alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop